Found: 41
Select item for more details and to access through your institution.
New Levodopa Infusion Systems for Advanced Parkinson's Disease.
- Published in:
- touchREVIEWS in Neurology, 2024, v. 20, n. 1, p. 23
- By:
- Publication type:
- Article
Has the COVID-19 Pandemic Led to a Switch in the Volatility of Biopharmaceutical Companies?
- Published in:
- Mathematics (2227-7390), 2023, v. 11, n. 14, p. 3116, doi. 10.3390/math11143116
- By:
- Publication type:
- Article
Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients.
- Published in:
- Ophthalmology & Therapy, 2022, v. 11, n. 3, p. 1147, doi. 10.1007/s40123-022-00493-z
- By:
- Publication type:
- Article
NUEVOS DESARROLLOS EN EL SECTOR FARMACÉUTICO. LAS RESOLUCIONES DE ARCHIVO DE LA CNMC EN "INHALADORES ASTRAZENECA" Y "ABBVIE".
- Published in:
- Actualidad Jurídica (1578-956X), 2021, n. 56, p. 166
- By:
- Publication type:
- Article
Population pharmacokinetics of adalimumab biosimilar adalimumab‐adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 11, p. 2274, doi. 10.1111/bcp.14330
- By:
- Publication type:
- Article
Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study.
- Published in:
- British Journal of Dermatology, 2019, v. 181, n. 6, p. 1177, doi. 10.1111/bjd.18029
- By:
- Publication type:
- Article
Elagolix for endometriosis: all that glitters is not gold.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Investigation of possible aqueous phase formation during vaporization of sevoflurane.
- Published in:
- Journal of Anaesthesiology Clinical Pharmacology, 2019, v. 35, n. 1, p. 76, doi. 10.4103/joacp.JOACP_53_18
- By:
- Publication type:
- Article
AbbVie's Venclexta Access Solutions.
- Published in:
- 2018
- Publication type:
- Product Review
Venclexta Approved in Combination for Older Adults with Acute Myeloid Leukemia.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 23
- Publication type:
- Article
Ethical drug updates: The latest drug announcements and PBS listings.
- Published in:
- 2018
- Publication type:
- Product Review
Company Profiles.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, p. 55, doi. 10.1111/ajco.12991
- Publication type:
- Article
Content marketing at AbbVie.
- Published in:
- Journal of Brand Strategy, 2018, v. 6, n. 4, p. 318
- By:
- Publication type:
- Article
Sustaining an efficient and effective CHO cell line development platform by incorporation of 24‐deep well plate screening and multivariate analysis.
- Published in:
- Biotechnology Progress, 2018, v. 34, n. 1, p. 175, doi. 10.1002/btpr.2584
- By:
- Publication type:
- Article
Ethical drug updates: The latest drug announcements and PBS listings.
- Published in:
- 2017
- Publication type:
- Product Review
Company Profiles.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, p. 65, doi. 10.1111/ajco.12720
- Publication type:
- Article
Should patients be advised not to drive for 4 days after isoflurane anaesthesia?
- Published in:
- 2017
- By:
- Publication type:
- editorial
Good 2016 for US pharma.
- Published in:
- Chemistry & Industry, 2017, v. 81, n. 2, p. 10, doi. 10.1002/cind.812_3x
- Publication type:
- Article
Sponsors.
- Published in:
- Andrology, 2016, v. 4, p. 95, doi. 10.1111/andr.12272
- Publication type:
- Article
Paritaprevir/ritonavir/ombitasvir plus dasabuvir/Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin.
- Published in:
- Australian Prescriber, 2016, v. 39, n. 4, p. 141, doi. 10.18773/austprescr.2016.045
- Publication type:
- Article
Hep C circuitbreaker.
- Published in:
- Australian Journal of Pharmacy, 2016, p. 6
- Publication type:
- Article
Top Foreign Corporate Citizens.
- Published in:
- Corporate Knights, 2016, v. 15, n. 3, p. 36
- Publication type:
- Article
SID 2015 Contributors.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 12, p. 3212, doi. 10.1038/jid.2015.397
- Publication type:
- Article
AbbVie buys last available priority voucher for $350 million.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 11, p. 1120, doi. 10.1038/nbt1115-1120
- By:
- Publication type:
- Article
Industry chases pan-genotypic and shorter HCV treatments.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 575, doi. 10.1038/nbt0615-575
- By:
- Publication type:
- Article
AbbVie pays $21 billion for Pharmacyclics' BTK inhibitor.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 4, p. 227, doi. 10.1038/nrd4605
- By:
- Publication type:
- Article
Seven days: 6-12 March 2015.
- Published in:
- Nature, 2015, v. 519, n. 7542, p. 134, doi. 10.1038/519134a
- Publication type:
- Article
SOUTHEASTERN PENNSYLVANIA TRANSPORTATION AUTHORITY v. ABBVIE INC./JAMES RIZZOLO v. ABBVIE INC.
- Published in:
- 2015
- Publication type:
- Opinion
Taxing issue.
- Published in:
- 2014
- Publication type:
- Opinion
Big-cap buying bonanza trickles down to small biotech.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 11, p. 1077, doi. 10.1038/nbt1114-1077
- By:
- Publication type:
- Article
First PI3k inhibitor launches into crowded hematology markets.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 963, doi. 10.1038/nbt1014-963
- By:
- Publication type:
- Article
Patent watch: Stelara safe after IL-12 antibody dispute.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 9, p. 647, doi. 10.1038/nrd4423
- By:
- Publication type:
- Article
Company Profiles.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, p. 47, doi. 10.1111/ajco.12224
- Publication type:
- Article
AbbVie drops transparency fight.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 6, p. 507, doi. 10.1038/nbt0614-507b
- By:
- Publication type:
- Article
15 March News.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 6, p. i, doi. 10.1093/cid/ciu047
- Publication type:
- Article
NIH denies march-in rights on Norvir patent.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 898, doi. 10.1038/nrd4198
- By:
- Publication type:
- Article
Small nanobody drugs win big backing from pharma.
- Published in:
- Nature Medicine, 2013, v. 19, n. 11, p. 1355, doi. 10.1038/nm1113-1355
- By:
- Publication type:
- Article
ASQ NEWS.
- Published in:
- Quality Progress, 2013, v. 46, n. 10, p. 17
- Publication type:
- Article
Deal watch: AbbVie invests in pioneering celiac disease therapy.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 497, doi. 10.1038/nrd4063
- By:
- Publication type:
- Article
Inside AbbVie.
- Published in:
- Australian Journal of Pharmacy, 2013, v. 94, n. 1115, p. 17
- Publication type:
- Article
AbbVie launches Down Under.
- Published in:
- Australian Journal of Pharmacy, 2013, v. 94, n. 1114, p. 61
- Publication type:
- Article